GoodRx (GDRX)
(Delayed Data from NSDQ)
$8.59 USD
+0.44 (5.40%)
Updated Aug 27, 2024 04:00 PM ET
After-Market: $8.59 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for GoodRx Holdings, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -8.87 | -32.83 | -25.25 | -293.62 | 66.05 |
Depreciation/Amortization & Depletion | 111.05 | 57.59 | 37.98 | 21.82 | 16.95 |
Net Change from Assets/Liabilities | -20.58 | -20.29 | -11.80 | -32.46 | -4.82 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 56.69 | 142.31 | 177.85 | 435.60 | 5.10 |
Net Cash From Operating Activities | 138.29 | 146.78 | 178.78 | 131.34 | 83.29 |
Property & Equipment | -55.77 | -55.21 | -34.46 | -35.82 | -5.75 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -140.28 | -140.27 | -55.79 | -31.31 |
Investments | 0.00 | -15.01 | -4.01 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -55.77 | -210.50 | -178.73 | -91.62 | -37.06 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -96.64 | -92.56 | 35.02 | 992.87 | 4.67 |
Issuance (Repayment) of Debt | -5.27 | -7.03 | -7.03 | -7.03 | -57.23 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -65.48 | -20.64 | -58.52 | -80.02 | -2.21 |
Net Cash from Financing Activities | -167.40 | -120.23 | -30.53 | 905.82 | -54.78 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -84.87 | -183.94 | -30.48 | 945.54 | -8.55 |
Cash at Beginning of Period | 757.17 | 941.11 | 971.59 | 26.05 | 34.60 |
Cash at End of Period | 672.30 | 757.17 | 941.11 | 971.59 | 26.05 |
Diluted Net EPS | -0.02 | -0.08 | -0.06 | -1.07 | 0.18 |
Fiscal Year End for GoodRx Holdings, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 5.69 | -1.01 | -8.87 | 17.00 | 55.50 |
Depreciation/Amortization & Depletion | 34.57 | 16.78 | 111.05 | 66.60 | 32.73 |
Net Change from Assets/Liabilities | -41.58 | 0.83 | -20.58 | 5.75 | -10.35 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 53.62 | 25.99 | 56.69 | 33.07 | -15.72 |
Net Cash From Operating Activities | 52.29 | 42.59 | 138.29 | 122.42 | 62.15 |
Property & Equipment | -37.84 | -20.62 | -55.77 | -42.89 | -29.25 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -37.84 | -20.62 | -55.77 | -42.89 | -29.25 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -140.60 | -150.64 | -96.64 | -21.12 | -16.52 |
Issuance (Repayment) of Debt | -5.27 | -3.52 | -5.27 | -5.27 | -3.52 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -15.97 | -6.81 | -65.48 | -15.40 | -8.05 |
Net Cash from Financing Activities | -161.84 | -160.97 | -167.40 | -41.79 | -28.08 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -147.39 | -139.00 | -84.87 | 37.74 | 4.82 |
Cash at Beginning of Period | 672.30 | 672.30 | 757.17 | 757.17 | 757.17 |
Cash at End of Period | 524.90 | 533.30 | 672.30 | 794.91 | 761.99 |
Diluted Net EPS | 0.02 | 0.00 | -0.06 | -0.09 | 0.14 |